| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | UTHR | Common Stock | Options Exercise | $666K | +6K | +16.44% | $111.00 | 42.5K | Mar 17, 2022 | Direct | F1, F2 |
| transaction | UTHR | Common Stock | Sale | -$91.3K | -504 | -1.19% | $181.18 | 42K | Mar 17, 2022 | Direct | F1, F3 |
| transaction | UTHR | Common Stock | Sale | -$704K | -3.87K | -9.21% | $182.14 | 38.1K | Mar 17, 2022 | Direct | F1, F4 |
| transaction | UTHR | Common Stock | Sale | -$235K | -1.28K | -3.36% | $183.25 | 36.8K | Mar 17, 2022 | Direct | F1, F5 |
| transaction | UTHR | Common Stock | Sale | -$64.5K | -350 | -0.95% | $184.15 | 36.5K | Mar 17, 2022 | Direct | F1, F6 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | UTHR | Stock Options | Options Exercise | $0 | -6K | -10.25% | $0.00 | 52.6K | Mar 17, 2022 | Common Stock | 6K | $111.00 | Direct | F1, F7 |
| Id | Content |
|---|---|
| F1 | This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. |
| F2 | Includes 118 shares acquired on March 4, 2022, under the United Therapeutics Corporation Employee Stock Purchase Plan. |
| F3 | This transaction was executed in multiple trades at prices ranging from $180.56 to $181.465. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F4 | This transaction was executed in multiple trades at prices ranging from $181.62 to $182.505. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F5 | This transaction was executed in multiple trades at prices ranging from $182.75 to $183.6375. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F6 | This transaction was executed in multiple trades at prices ranging from $183.99 to $184.20. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F7 | These performance-based stock options were initially awarded on March 15, 2018, subject to a three-year performance condition tied to average cash profits during 2018-2020, and vested on March 15, 2021. |